JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 176 filers reported holding JUNO THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.85 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $6,203,000 | +3.6% | 135,700 | +1.6% | 0.01% | 0.0% |
| Q3 2017 | $5,989,000 | +92.1% | 133,500 | +28.0% | 0.01% | +75.0% |
| Q2 2017 | $3,118,000 | +34.7% | 104,300 | 0.0% | 0.00% | +33.3% |
| Q1 2017 | $2,314,000 | +17.7% | 104,300 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,966,000 | -15.9% | 104,300 | +33.9% | 0.00% | -25.0% |
| Q3 2016 | $2,338,000 | -23.9% | 77,900 | -2.5% | 0.00% | -20.0% |
| Q2 2016 | $3,071,000 | +12.9% | 79,900 | +8.0% | 0.01% | 0.0% |
| Q1 2016 | $2,720,000 | +4.5% | 74,000 | +25.0% | 0.01% | -16.7% |
| Q4 2015 | $2,603,000 | – | 59,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|